Description

4-(6-Oxo-1,6-Dihydropyridazin-3-Yl)Benzoic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique pyridazinone-benzoic acid hybrid structure. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly in areas requiring complex heterocyclic scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-inflammatory targets.
• Organic Synthesis Building Block: Used in medicinal chemistry for constructing complex heterocyclic molecules due to its reactive carboxylic acid and pyridazinone functional groups.
• Research & Development (R&D): Essential for academic and industrial research programs focused on discovering new bioactive compounds and studying structure-activity relationships (SAR).
• Agrochemical Research: Potential application as an intermediate in the development of new herbicides or plant growth regulators, leveraging its heterocyclic core.
• Material Science Precursor: Can be utilized in the synthesis of specialized organic ligands or monomers for advanced polymeric materials.

Basic Information

Product Name	4-(6-Oxo-1,6-Dihydropyridazin-3-Yl)Benzoic Acid
CAS No.	249292-44-2
Molecular Formula	C12H8N2O3
Molecular Weight	228.20 g/mol
Synonyms	3-(4-Carboxyphenyl)-6(1H)-pyridazinone; 4-(6-Oxo-1,6-dihydro-3-pyridazinyl)benzoic Acid; 4-(6-Oxo-1,6-dihydropyridazin-3-yl)benzoic acid; Benzoic acid, 4-(1,6-dihydro-6-oxo-3-pyridazinyl)-; 3-(4-Carboxyphenyl)-1,6-dihydro-6-pyridazinone; 4-(6-Oxo-1,6-dihydro-pyridazin-3-yl)-benzoic acid
EINECS	Contact for details

Quality Control

Our 4-(6-Oxo-1,6-Dihydropyridazin-3-Yl)Benzoic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) documenting batch-specific results are available upon request, providing full traceability and compliance data.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.